Polycystic Ovarian Syndrome is the commonest endocrinological disorder of women in reproductive age group. It characterized by oligo/anovulation, hyperandrogenism, and raised Luteinizing Hormone: Follicle Stimulating Hormone ratio. Elevated levels Hormone, contribute to hyperandrogenism altered ratio between Hormone. The present case report discusses Ayurvedic management - a diagnosed Syndrome....

Polycystic Ovary Syndrome (PCOS) is a reproductive, hormonal, and metabolic disorder frequently associated with insulin resistance, hyperandrogenism, chronic inflammation, oxidative stress. Resveratrol naturally occurring polyphenolic stilbene found in trace amounts some food items. It has been extensively used as treatment option for disorders but its use PCOS limited. This review emphasizes t...

Polycystic ovarian syndrome can be defined as an endocrine disorder that most affects the reproductive system of women childbearing age; its causes are not exactly known. However, majority experts agree it is a multifactorial entity with multiple factors. Genetics becoming increasingly important. In recent years, several genes involved in pathogenic processes this have been identified. Within t...

This paper presents a comprehensive exploration of various aspects related to specific disease, aiming enhance the understanding its clinical manifestations and implications. The introduction delves into historical context emerging challenges associated with providing basis for subsequent discussions. Prevalence rates are analyzed through an extensive review epidemiological data, shedding light...

The polycystic ovarian syndrome is an endocrine disorder with a high prevalence affecting reproductive-aged women and adolescent girls. most common symptoms are infertility, numerous cysts, hyperandrogenism, menstrual cycle abnormalities. disease has great impact on patients, impairing their quality of life. Bearing that in mind, innovative therapeutic approaches needed. We aim to describe curr...

BACKGROUND Polycystic ovary syndrome is the most frequently seen endocrine disorder in women of reproductive age with a prevalence of about 10%. AIMS To investigate the efficiency of growth differentiation factor 9 and bone morphogenetic protein 15 during folliculogenesis in a dehydroepiandrosterone-induced mouse Polycystic ovary syndrome model. STUDY DESIGN Animal experimentation. METHOD...

As a universally common endocrinopathy in women of reproductive age, the polycystic ovarian syndrome is characterized by composite clinical phenotypes reflecting the contributions of reproductive impact of ovarian dysfunction and metabolic abnormalities with widely varying symptoms resulting from interference of the genome with the environment through integrative biological mechanisms including...